Publication | Closed Access

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

HepatologyMedicineTranscatheter Arterial ChemoembolisationPharmacotherapyOrantinib Versus PlaceboLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaPhase 3Anesthesiology